Shanghai Universal Biotech Co Ltd. Stock Analysis 301166.SZ

Shanghai Universal Biotech Co., Ltd. engages in the provision of life science research services. The company is headquartered in Shanghai, Shanghai and currently employs 655 full-time employees. The company went IPO on 2021-12-28. The firm is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.